APR EXECUTIVE INTERVIEW: Turning Complex Molecules into Medicines: Leveraging Advanced Formulation Technologies to Enable Solubility and Permeability
In this interview with American Pharmaceutical Review's Editor-in-Chief Mike Auerbach, Serán's President & CEO, Dan Smithey discusses the increasing complexity of molecules, barriers to bioavailability and the enabling science and technologies being leveraged to achieve permeability and solubility. The article explores existing and novel formulation technologies and considerations for each. Dr. Smithey, breaks down Serán's comprehensive approach to address these challenges to help Serán's clients deliver complex medicines to patients sooner.
Learning Objectives:
- Understand the barriers to achieving acceptable pharmacokinetics for oral delivery
- Existing and novel approaches to enabling solubility and permeability for oral solid dosage forms
- Understanding options being explored for improved bioavailability through advanced injectable formulations
Read this complimentary article to learn more about these and other bioavailability enhancing technologies and a development approach that can dramatically reduce time to clinic and launch. Read today!
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com